BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16960339)

  • 21. Expression of GATA-1 in a non-hematopoietic cell line induces beta-globin locus control region chromatin structure remodeling and an erythroid pattern of gene expression.
    Layon ME; Ackley CJ; West RJ; Lowrey CH
    J Mol Biol; 2007 Feb; 366(3):737-44. PubMed ID: 17196618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of hematopoietic GATA transcription factor expression in mouse and human dendritic cells.
    Scheenstra MR; Salunkhe V; De Cuyper IM; Hoogenboezem M; Li E; Kuijpers TW; van den Berg TK; Gutiérrez L
    Blood Cells Mol Dis; 2015 Dec; 55(4):293-303. PubMed ID: 26460250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of Ets-1 in human hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiation.
    Lulli V; Romania P; Morsilli O; Gabbianelli M; Pagliuca A; Mazzeo S; Testa U; Peschle C; Marziali G
    Cell Death Differ; 2006 Jul; 13(7):1064-74. PubMed ID: 16294212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1.
    Fujiwara Y; Browne CP; Cunniff K; Goff SC; Orkin SH
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12355-8. PubMed ID: 8901585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription factor GATA-2 is expressed in erythroid, early myeloid, and CD34+ human leukemia-derived cell lines.
    Nagai T; Harigae H; Ishihara H; Motohashi H; Minegishi N; Tsuchiya S; Hayashi N; Gu L; Andres B; Engel JD
    Blood; 1994 Aug; 84(4):1074-84. PubMed ID: 7519472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GATA transcription factors regulate the expression of the human eosinophil-derived neurotoxin (RNase 2) gene.
    Qiu Z; Dyer KD; Xie Z; Rådinger M; Rosenberg HF
    J Biol Chem; 2009 May; 284(19):13099-109. PubMed ID: 19279013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased expression of transcription factor GATA-2 in haematopoietic stem cells in patients with aplastic anaemia.
    Fujimaki S; Harigae H; Sugawara T; Takasawa N; Sasaki T; Kaku M
    Br J Haematol; 2001 Apr; 113(1):52-7. PubMed ID: 11328281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of GATA-1 in normal and neoplastic hemopoiesis.
    Migliaccio AR; Rana RA; Vannucchi AM; Manzoli FA
    Ann N Y Acad Sci; 2005 Jun; 1044():142-58. PubMed ID: 15958708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic transcription factor GATA-2 promotes upregulation of alpha globin and cell death in FL5.12 cells.
    Brecht K; Simonen M; Kamke M; Heim J
    Apoptosis; 2005 Oct; 10(5):1063-78. PubMed ID: 16151640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of GATA family transcriptional factors in haematological malignancies: A review.
    Abunimye DA; Okafor IM; Okorowo H; Obeagu EI
    Medicine (Baltimore); 2024 Mar; 103(12):e37487. PubMed ID: 38518015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Essential role of GATA transcriptional factors in the activation of mast cells.
    Masuda A; Hashimoto K; Yokoi T; Doi T; Kodama T; Kume H; Ohno K; Matsuguchi T
    J Immunol; 2007 Jan; 178(1):360-8. PubMed ID: 17182574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
    Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
    Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human phenotypes associated with GATA-1 mutations.
    Ciovacco WA; Raskind WH; Kacena MA
    Gene; 2008 Dec; 427(1-2):1-6. PubMed ID: 18930124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eosinophils from lineage-ablated Delta dblGATA bone marrow progenitors: the dblGATA enhancer in the promoter of GATA-1 is not essential for differentiation ex vivo.
    Dyer KD; Czapiga M; Foster B; Foster PS; Kang EM; Lappas CM; Moser JM; Naumann N; Percopo CM; Siegel SJ; Swartz JM; Ting-De Ravin S; Rosenberg HF
    J Immunol; 2007 Aug; 179(3):1693-9. PubMed ID: 17641035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone demethylase LSD1-mediated repression of GATA-2 is critical for erythroid differentiation.
    Guo Y; Fu X; Jin Y; Sun J; Liu Y; Huo B; Li X; Hu X
    Drug Des Devel Ther; 2015; 9():3153-62. PubMed ID: 26124638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
    Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
    Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GATA switches as developmental drivers.
    Bresnick EH; Lee HY; Fujiwara T; Johnson KD; Keles S
    J Biol Chem; 2010 Oct; 285(41):31087-93. PubMed ID: 20670937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essential and instructive roles of GATA factors in eosinophil development.
    Hirasawa R; Shimizu R; Takahashi S; Osawa M; Takayanagi S; Kato Y; Onodera M; Minegishi N; Yamamoto M; Fukao K; Taniguchi H; Nakauchi H; Iwama A
    J Exp Med; 2002 Jun; 195(11):1379-86. PubMed ID: 12045236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractionation of mature eosinophils in GATA-reporter transgenic mice.
    Kim K; Suzuki N; Ohneda K; Minegishi N; Yamamoto M
    Tohoku J Exp Med; 2010 Feb; 220(2):127-38. PubMed ID: 20139664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genetic control of hematopoiesis].
    Roméo PH
    C R Seances Soc Biol Fil; 1997; 191(1):105-11. PubMed ID: 9181132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.